Novel Binding Partners and Differentially Regulated Phosphorylation Sites Clarify Eps8 as a Multi-Functional Adaptor

Eps8 is involved in both cell signalling and receptor trafficking. It is a known phosphorylation substrate for two proteins involved in the fibroblast growth factor receptor (FGFR) signalling pathway: the receptor itself and Src. Here we report a differential proteomic analysis of Eps8 aimed to identify specific FGFR and Src family kinase dependent phosphosites and co-associated phosphodependent binding partners. This study reveals a total of 22 Eps8 pTyr and pSer/Thr phosphorylation sites, including those that are dependent on Src family and FGFR kinase activity. Peptide affinity purification of proteins that bind to a selection of the pTyr phosphosites has identified a range of novel Eps8 binding partners including members of the intracellular vesicle trafficking machinery (clathrin and AP-2), proteins which have been shown to regulate activated receptor trafficking (NBR1 and Vav2), and proteins involved in receptor signalling (IRS4 and Shp2). Collectively this study significantly extends the understanding of Eps8 post-translational modification by regulated phosphorylation, identifies novel Eps8 binding partners implicated in receptor trafficking and signalling, and confirms the functions of Eps8 at the nexus of receptor signalling and vesicular trafficking.

[1]  J. Heath,et al.  Regulation of fibroblast growth factor receptor signalling and trafficking by Src and Eps8 , 2013, Journal of Cell Science.

[2]  D. Perrais,et al.  A High Precision Survey of the Molecular Dynamics of Mammalian Clathrin-Mediated Endocytosis , 2011, Microscopy and Microanalysis.

[3]  Shuang Huang,et al.  Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. , 2010, Cancer research.

[4]  J. Heath,et al.  Nbr1 Is a Novel Inhibitor of Ligand-Mediated Receptor Tyrosine Kinase Degradation , 2010, Molecular and Cellular Biology.

[5]  J. Iovanna,et al.  VAV2 regulates epidermal growth factor receptor endocytosis and degradation , 2010, Oncogene.

[6]  J. Heath,et al.  Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. , 2010, Cancer research.

[7]  H. Cooper,et al.  Differential Phosphoproteomics of Fibroblast Growth Factor Signaling: Identification of Src Family Kinase-Mediated Phosphorylation Events , 2010, Journal of proteome research.

[8]  A. Lamond,et al.  Establishment of a Protein Frequency Library and Its Application in the Reliable Identification of Specific Protein Interaction Partners* , 2009, Molecular & Cellular Proteomics.

[9]  W. Mckeehan,et al.  Novel phosphotyrosine targets of FGFR2IIIb signaling. , 2009, Cellular signalling.

[10]  G. Thomas,et al.  Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation , 2009, Oncogene.

[11]  S. Fujita,et al.  Identification and characterization of an insulin receptor substrate 4-interacting protein in rat brain: Implications for longevity , 2009, Neurobiology of Aging.

[12]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[13]  Heribert Hirt,et al.  Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks , 2008, Proteomics.

[14]  F. Boisvert,et al.  Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes , 2008, The Journal of cell biology.

[15]  D. Alessi,et al.  Identification of Protor as a novel Rictor-binding component of mTOR complex-2. , 2007, The Biochemical journal.

[16]  Yun-Ju Chen,et al.  EPS8 Facilitates Cellular Growth and Motility of Colon Cancer Cells by Increasing the Expression and Activity of Focal Adhesion Kinase* , 2007, Journal of Biological Chemistry.

[17]  Y. Higami,et al.  Identification of differentially expressed genes in senescence-accelerated mouse testes by suppression subtractive hybridization analysis , 2007, Mammalian Genome.

[18]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[19]  Andrea Disanza,et al.  Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8–IRSp53 complex , 2006, Nature Cell Biology.

[20]  K. Inoki,et al.  Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. , 2006, Genes & development.

[21]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[22]  Volker Brinkmann,et al.  Prohibitin is required for Ras-induced Raf–MEK–ERK activation and epithelial cell migration , 2005, Nature Cell Biology.

[23]  A. Pandey,et al.  Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) for Studying Dynamics of Protein Abundance and Posttranslational Modifications , 2005, Science's STKE.

[24]  Andrea Disanza,et al.  Eps8 controls actin-based motility by capping the barbed ends of actin filaments , 2004, Nature Cell Biology.

[25]  M. Mann,et al.  Tyrosine Phosphoproteomics of Fibroblast Growth Factor Signaling , 2004, Journal of Biological Chemistry.

[26]  J. Kornhauser,et al.  PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation , 2004, Proteomics.

[27]  Waltraud X. Schulze,et al.  A Novel Proteomic Screen for Peptide-Protein Interactions* , 2004, Journal of Biological Chemistry.

[28]  Ó. Escribano,et al.  Insulin receptor substrate‐4 signaling in quiescent rat hepatocytes and in regenerating rat liver , 2003, Hepatology.

[29]  Blagoy Blagoev,et al.  A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.

[30]  G. Lienhard,et al.  Insulin Receptor Substrate 4 Associates with the Protein IRAS* , 2002, The Journal of Biological Chemistry.

[31]  G. Scita,et al.  An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin–polymerizing machine , 2001, The Journal of cell biology.

[32]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[33]  Pier Paolo Di Fiore,et al.  The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5 , 2000, Nature.

[34]  M. Karas,et al.  Insulin Receptor Substrate-4 Enhances Insulin-like Growth Factor-I-induced Cell Proliferation* , 1999, The Journal of Biological Chemistry.

[35]  C. Betsholtz,et al.  EPS8 and E3B1 transduce signals from Ras to Rac , 1999, Nature.

[36]  M. Maa,et al.  Enhancement of tyrosyl phosphorylation and protein expression of eps8 by v-Src. , 1999, Biochimica et biophysica acta.

[37]  R. Carbone,et al.  Regulation of the tyrosine kinase substrate Eps8 expression by growth factors, v-Src and terminal differentiation , 1997, Oncogene.

[38]  S. Hubbard,et al.  Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. , 1997, Science.

[39]  T. Pawson,et al.  Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2 , 1997, The EMBO journal.

[40]  C. Piccoli,et al.  Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth , 1997, Oncogene.

[41]  P. Pelicci,et al.  Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation , 1995, Molecular and cellular biology.

[42]  L. Minichiello,et al.  Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF‐dependent mitogenic signals. , 1993, The EMBO journal.

[43]  E. Shi,et al.  Purification from human hepatoma cells of a 130-kDa membrane glycoprotein with properties of the heparin-binding growth factor receptor* , 1988 .

[44]  W. A. Yeudall,et al.  Role for EPS8 in squamous carcinogenesis. , 2009, Carcinogenesis.

[45]  Jürgen Cox,et al.  A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics , 2009, Nature Protocols.

[46]  W. Mckeehan,et al.  Purification form human hepatoma cells of a 130-kDa membrane glycoprotein with properties of the heparin-binding growth factor receptor. , 1988, Biochemical and biophysical research communications.